Sanitas says its strategy is good medicine for Jelfa

The foundations of Sanitas' strategy envisage that yet in 2006 the Jelenia Góra-based plant will increase its scale of operation, among others thanks to moving part of production from other plants of the group. "This should lead to an increase in the utilization of Jelfa's production capacity by 20%," said Saulius Jurgelenas, managing director of Sanitas. Plans concerning Jelfa also envisage creating an R&D center with the most promising projects receiving additional financing. However, at the same time it is almost sure that the company will be de-listed and, "it will be achieved either via purchasing shares from the market or a so-called 'squeeze out'. The decision will be taken within two to three weeks," said Jurgelenas. Sanitas itself is considering floating its shares on the Warsaw bourse, which could take place in 2007. (Puls Biznesu, p. 11) M.M.